TCM Ltd sets Sept 25 for 82nd AGM; e-voting opens Sept 22

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • TCM Limited schedules 82nd AGM for September 25, 2026, in Ernakulam
  • Remote e-voting open from September 22 to September 24, 2026
  • Book closure period set from September 19 to September 25, 2026
  • FY26 consolidated net loss widened to ₹599.6 million from profit of ₹151.4 million
powered bylight_fuzz_icon
49698255

*this image is generated using AI for illustrative purposes only.

TCM Limited has scheduled its 82nd Annual General Meeting (AGM) for Friday, September 25, 2026, at Bharat Hotel in Ernakulam. The company confirmed the dispatch of the AGM notice and financial statements for the year ended March 31, 2026, to members on September 1, 2026.

The meeting aims to approve the financial results showing a consolidated net loss of ₹599.6 million for FY26, a reversal from the net profit of ₹151.4 million recorded in the previous year. Consolidated total income fell to ₹2,070.0 million from ₹3,047.5 million in FY25.

E-Voting and Book Closure Details

Shareholders holding shares as on the cut-off date of September 18, 2026, are eligible to vote. The register of members and share transfers will remain closed from September 19, 2026, to September 25, 2026 (both dates inclusive).

Remote e-voting through Central Depository Services (India) Ltd (CDSL) will be open from September 22, 2026, at 9:00 am to September 24, 2026, at 5:00 pm. Members who have not cast their votes remotely may exercise their right via ballot form at the AGM venue.

Financial Performance Recap

The standalone entity reported a net loss of ₹363.4 million, compared to a profit of ₹326.4 million in FY25. Standalone total income was ₹1,853.3 million against total expenses of ₹2,219.6 million.

Metric Consolidated FY26 Consolidated FY25 Standalone FY26 Standalone FY25
Total Income ₹2,070.0 million ₹3,047.5 million ₹1,853.3 million ₹2,950.8 million
Total Expenses ₹2,672.5 million ₹2,911.0 million ₹2,219.6 million ₹2,639.3 million
Net Profit / (Loss) (₹599.6) million ₹151.4 million (₹363.4) million ₹326.4 million

What the Numbers Show

The financial results reveal a sharp divergence between operating performance and non-operating income. In the previous year, the company benefited from a substantial write-back of liabilities amounting to ₹423.0 million, which significantly boosted other income. For the current year, this write-back dropped to ₹59.5 million, removing a key support for the bottom line. Additionally, finance costs surged to ₹192.4 million on a consolidated basis, up from ₹59.1 million in the prior year, indicating increased leverage or borrowing activity that weighed heavily on profitability despite relatively stable operating expenses.

Business Operations and Strategy

The company continues operations across solar power, medical diagnostics, cattle feed, and real estate. The chemical manufacturing unit at Mettur remains suspended due to financial constraints and raw material shortages. In real estate, the company has entered into a memorandum of understanding with Asset Homes TCM Townships Pvt. Ltd. for the joint development of an 11-acre land parcel in Kalamassery. Construction is expected to commence in FY27 subject to statutory approvals.

Corporate Governance and Dividend

The Board of Directors did not recommend any dividend for FY26 due to the losses incurred during the year. The AGM agenda includes the reappointment of Mrs. Rani Jose as a director retiring by rotation. Additionally, shareholders are sought to approve the reappointment of independent directors Mr. Gopalakrishnan Mahesh and Mr. Jose Jacob for a second term of five years each.

Historical Stock Returns for TCM

1 Day5 Days1 Month6 Months1 Year5 Years
-3.11%+5.53%+24.43%+29.57%+12.76%+42.90%

What specific operational or strategic measures is TCM Limited implementing to reverse the FY26 net loss and return to profitability in FY27?

How will the surge in finance costs to ₹192.4 million impact the company's debt servicing capacity and future borrowing requirements?

What are the projected timelines and revenue contributions from the new 11-acre real estate joint development in Kalamassery once construction begins?

TCM launches poultry feed unit with 1,500 tonne monthly capacity

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • TCM Limited launches poultry feed production with a monthly capacity of 1,500 tonnes
  • Total investment of ₹2.50 crore funded entirely through internal accruals
  • Existing cattle feed capacity at Kalady plant stands at 1,000 tonnes per month
  • Initial utilization for poultry feed expected to be less than 20% in first six months
powered bylight_fuzz_icon
49875294

*this image is generated using AI for illustrative purposes only.

TCM Limited has launched a new poultry feed product at its leased facility in Palakkad, Kerala. The move adds approximately 1,500 tonnes of monthly production capacity to the company’s feed division.

The expansion is part of the company’s broader strategy to address evolving market demand within the feed sector. The facility, located in Pulinchode, operates from a commercial factory and office space of 10,760 sq ft owned by M/s Better Feeds Pvt Ltd.

Capacity and Utilization

The new capacity is exclusively for poultry feed production. TCM disclosed that initial utilization for the first six months is expected to be less than 20% of this proposed capacity.

This addition complements the company’s existing cattle feed operations at its Kalady plant, which has a current manufacturing capacity of 1,000 tonnes per month. For the quarter ended June 2026, the utilization of this existing cattle feed capacity stood at 50%.

Investment Details

The total investment required for the poultry feed launch is ₹2.50 crore. This amount covers machinery procurement and working capital needs. The entire expenditure will be financed through internal accruals.

Purpose Amount
Purchase of Machinery and tools ₹0.50 crore
Working Capital requirements ₹1.50 crore
Total ₹2.50 crore

What the Numbers Show

The capital structure of the investment highlights a heavy reliance on working capital rather than fixed assets. Working capital requirements account for 60% of the total ₹2.50 crore outlay, suggesting that raw material inventory and receivables management will be critical drivers of cash flow for this new vertical in its early stages.

Historical Stock Returns for TCM

1 Day5 Days1 Month6 Months1 Year5 Years
-3.11%+5.53%+24.43%+29.57%+12.76%+42.90%

How will the low initial utilization rate of less than 20% impact TCM's short-term cash flow and return on investment for this new poultry feed vertical?

What specific competitive advantages or pricing strategies does TCM plan to employ to capture market share in Kerala's crowded poultry feed sector?

Will the expansion into poultry feed lead to synergies in raw material procurement with the existing cattle feed operations at the Kalady plant?

More News on TCM

1 Year Returns:+12.76%